A growing number of individuals in their 30s and 40s are experiencing early-onset joint degeneration, termed "bone burnout," ...

Researchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms in patients with psoriasis and psoriatic arthritis, outperforming both ...

Osteoarthritis of the hip is a leading cause of chronic disability. The cycling and education intervention (CLEAT) trial aimed to compare the clinical and cost-effectiveness of the cycling against hip ...

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active ...

Psoriatic arthritis (PsA) is a chronic, immune-mediated, inflammatory disease characterized by peripheral joint inflammation, enthesitis (pain where the bone, tendon and ligament meet), dactylitis ...

'The Daily Show' gets new host amid late-night upheaval Hundreds of thousands of people warned to "stay out of the water" My ex-husband’s benefit will be $2,600 at retirement age, and mine is ...

Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with osteoarthritis undergoing total joint arthroplasty, suggesting the ...

Serum levels of C1M, a biochemical marker of type I collagen degradation, may predict progression of total joint damage in patients with early arthritis.

Key messages The evidence is still developing, and future studies may change our conclusions. We are not confident that one surgical approach (way of accessing the hip joint) compared to another leads ...